Report from SMI: SPECT test of apoptosis identifies vulnerable carotid artery plaques

Article

One of the first human studies of technetium-labeled Annexin 5A (AA5) has found that the agent can distinguish between stable and unstable carotid plaques, potentially helping vascular surgeons select patients for carotid artery endarterectomy.

One of the first human studies of technetium-labeled Annexin 5A (AA5) has found that the agent can distinguish between stable and unstable carotid plaques, potentially helping vascular surgeons select patients for carotid artery endarterectomy.

Dr. Leonard Hofstra, an associate professor of cardiology, and colleagues in the cardiovascular research institute at Maastricht University Hospital in the Netherlands studied 16 patients with confirmed severe carotid artery stenosis to determine if the agent's known ability to identify regions of high apoptotic activity could noninvasively identify unstable plaques.

Patients were examined with Tc-99m AA5 SPECT before undergoing previously scheduled carotid endarterectomy. The degree of carotid stenosis was 70% to 90%, according to coauthor Sander Wolters. Findings were presented at the 2005 Society for Molecular Imaging meeting in Cologne, Germany.

Morphologic features confirmed that unstable plaques in four patients had positive AA5 scans, according to Wolters. Histologic characteristics included large necrotic cores, macrophagic infiltration, and the presence of AA5, a biomarker of apoptosis.

Nine of 10 cases where no AA5 uptake was observed correlated with histologically confirmed stable atherosclerotic disease. Patient population size was not large enough to statistically calculate the test's accuracy, Wolters said.

The findings build on initial results based on four patients reported in The New England Journal of Medicine.

Although the AA5 scientific research is the cutting edge of molecular imaging, the clinical problem it seeks to address has dogged physicians and healthcare policymakers since the 1980s. The appropriateness of carotid endarterectomy was addressed in a landmark healthcare utilization study from Dartmouth University that found wide variation in the U.S. The more recent European Carotid Surgery Trial and North American Carotid Surgery Trail found that 70% of the expensive and potentially risky elective surgeries are unnecessary, Wolters said. About 500,000 endarerectomies are performed annually in the U.S.

The Maatricht group is laying the groundwork for a multicenter trial of 100 to 200 subjects to determine definitively if plaque stability, measured with Tc-99m AA5 SPECT, can address this problem.

"We want to provide clinicians with a new diagnostic protocol that tells them if a plaque is unstable or stable instead of large or small," he said.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.